Consider Clinical Therapeutics for Your Next Psychiatry Submission

As the incoming topic editor for psychiatry, I look forward to submissions that help inform psychiatric therapeutics, have a new story to tell, or have a new way to tell an old story. We invite original research reports, case series, and scholarly reviews that cover psychiatric therapeutics (pharmacotherapy, neuromodulation, and other therapies), therapeutic drug monitoring, adverse effects, pharmacogenetics, polypharmacy and off-label prescribing, as well as diagnostics, treatment outcomes, and innovations in drug and biologics research. In addition, Clinical Therapeutics continues to welcome pharmacoeconomic analyses and health policy perspectives in psychiatry. Dr Markowitz remains as topic editor for pharmacology, pharmacokinetics, and pharmacodynamics, so there is some overlap where we will collaborate.

Although Clinical Therapeutics ordinarily charges page fees to publish, fee waivers are available when asked for at the time of submission. Fee waivers can be granted if your institution, research, study, or grant does not support funds for publication. The ability to pay the fee does not influence decisions regarding the acceptance of a manuscript, which is solely dependent on the peer-review process. There is also the potential to make articles free to access.